As Americans prepare for Christmas, it’s safe to say there were plenty of jokes at family tables this year about the explosion of popularity of GLP-1 weight loss drugs. As of August, 12 percent of Americans reported using these drugs, and at least 35 percent are considering the treatment originally intended for type 2 diabetes, […]
Author Archives: David Clement
David Clement is the North American Affairs Manager with the Consumer Choice Center. He wrote this for InsideSources.com.
